Tag: T2D
AASD 2026 18th Scientific Sessions
Asian Association for the Study of Diabetes 18th Scientific Sessions: Human Cell Design presents its latest research on GLP1-R KD EndoC-βH5® Scientists from Human Cell Design participated in the AASD2026 of the Japan Diabetes Society (JDS), in Osaka (Japan). During the event, our team shared our latest results on the 𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝘁𝗶𝗰 𝗗𝗶𝘀𝘀𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗧𝗶𝗿𝘇𝗲𝗽𝗮𝘁𝗶𝗱𝗲 𝗦𝗶𝗴𝗻𝗮𝗹𝗶𝗻𝗴 𝗶𝗻 𝗛𝘂𝗺𝗮𝗻 𝗘𝗻𝗱𝗼𝗖-𝗕𝗛𝟱 𝗖𝗲𝗹𝗹𝘀: 𝗜𝘀
American Diabetes Association’s 85th Scientific Sessions
American Diabetes Association’s 85th Scientific Sessions: Human Cell Design presents its latest research on glucolipotoxicity Scientists from Human Cell Design participated in the American Diabetes Association’s 85th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention, and care in Chicago (IL, USA). During the event, our team shared our latest results on glucolipotoxicity and T2D-relevant phenotypes using
American Diabetes Association’s 84th Scientific Sessions
American Diabetes Association’s 84th Scientific Sessions: Human Cell Design presents its latest cAMP assay Scientists from Human Cell Design participated in the American Diabetes Association’s 84th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention, and care in Orlando (USA). During the event, our team presented how our rapid and high-resolution cAMP assay can enhance the evaluation
T1D and T2D Inflammation Assay
Reveal your drug’s anti-inflammatory and beta cell protection potential Using Endoc-BH5® cells, the Cytokine-Mediated Human Beta Cell Inflammation Assay replicates in vitro the clinically observed response of human pancreatic beta cells to cytokine-induced inflammation process observed in Type 2 and Type 1 Diabetes. Key advantages: Discover how this assay will enable you to evaluate the anti-inflammatory and beta cell protection
GLTx EndoC-βH5®
Revolutionize Your Glucolipotoxicity-Mediated T2D Research Open new avenue using a unique clinically relevant cell model. GLTx EndoC-βH5® is a new human pancreatic beta cell line that has been specifically designed to recapitulate pathological glucolipotoxicity-induced dysfunction as observed in Type 2 Diabetes patients. GLTx EndoC-βH5® cell line offers you:
Human Cell Design scientists are proud to present at the 59th EASD two new and innovative human T1D & T2D cell models
Human Cell Design scientists are proud to present at the 59th EASD two new and innovative human T1D & T2D cell models Hamburg, October 2-6, 2023 This year many EASD talks demonstrated the relevance of Endoc-βH5® human beta cells as the one of Arnaud Dance from the Dr. Anne Bonnefond group. In parallel, Human Cell design scientists are proud to
EndoC-βH5® brings you absolute flexibility: A unique thaw and go human beta cell solution
Don’t always wait for human pancreatic islet samples. EndoC-βH5 is a flexible solution of human beta cells that can be used at any time. See here an illustration of the use of EndoC-βH5® cells from thawing to functional assay (e.g. glucose stimulated insulin secretion, GSIS). EndoC-βH5® cells are fully mature human pancreatic beta cells that exhibit characteritics of native beta cell (i.e.
Latest News
Human Cell Design provides human cells and services to accelerate and secure innovative, safe and clinically relevant scientific progress and pharmaceutical products for human health.